Benzinga | Dec 14, 2020 06:35AM EST

SVB Leerink Maintains Outperform on Alexion Pharmaceuticals, Raises Price Target to $200

SVB Leerink maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and raises the price target from $159 to $200.